These stocks should outperform as the Iran deal is finalized, says UBS

UBS says a U.S.-Iran settlement could benefit stocks that were hurt by the Middle East conflict and names Southwest Airlines and Eastman Chemical as potential outperformers. Jefferies raised Southwest's price target to $44 from $37, while JPMorgan upgraded Eastman Chemical to overweight and lifted its target to $80 from $70. Southwest is up 15% this year and Eastman has gained almost 15% in 2026, suggesting the market is already partially pricing in improvement.

Analysis

A geopolitical de-escalation is a classic second-order margin reset trade: the biggest upside is not the headline beneficiaries themselves, but the adjacent names whose earnings beta to energy and logistics costs has been artificially compressed. LUV screens as a cleaner operating leverage vehicle than a generic airline long because its rerating can come from both lower input-cost risk and a multiple expansion off the perception that fare discipline can hold without an oil shock. EMN is more interesting as a cyclical duration trade: if conflict risk fades, the market can stop pricing “defensive scarcity” into materials and start discounting a late-cycle recovery in industrial demand, which is where earnings inflection can outrun consensus by several quarters.

The market may be underestimating how quickly a settlement changes positioning rather than fundamentals. These are exactly the kind of names that have been left behind by crowded growth and AI flows; if volatility compresses, systematic re-risking can force a fast catch-up move over days to weeks. The cleaner setup is not absolute long exposure, but a pair against sectors that had benefited from war-related hedging or commodity optionality, because the unwind trade tends to be sharper than the initial rally.

The key risk is that the deal becomes a “risk-off brief rally” rather than a durable regime change. If implementation stalls, ceasefire terms fray, or oil fails to stay subdued, the trade decays quickly and the market will fade the rerating back to earnings quality and balance-sheet reality. For both LUV and EMN, the market will want proof in management commentary and forward bookings/orders over the next 1-2 reporting cycles, not just a headline settlement.

Consensus may also be too linear on the benefit to airlines: lower fuel helps, but it also invites capacity rationalization reversals, which can pressure yields if competitors get aggressive. EMN’s upside is more contrarian because a normalization in raw-material volatility can improve customer planning, restocking, and contract visibility, creating a better-than-expected operating backdrop even before end-demand fully recovers.

Key Decisions for Investors

• Go long LUV over the next 1-3 sessions if the settlement is formally signed; target a 5-8% tactical move with a stop below the pre-signing breakout level, because the stock should benefit most from a fast decline in fuel-risk premium and factor rotation out of crowded defensives.
• Initiate a 2-4 week long EMN / short XLB or short a higher-beta chemical basket; EMN has the cleaner earnings inflection profile if industrial sentiment improves, while the short leg hedges the broader materials beta.
• Buy near-dated LUV call spreads for the first 30-45 days post-signing; upside is convex if the market extrapolates lower jet fuel and better demand visibility, while premium outlay caps downside if the deal disappoints.
• Use any post-announcement spike to fade crowded commodity-sensitive hedges and rotate into LUV and EMN only on pullbacks of 2-3%; the entry discipline matters because the first move will likely be sentiment-driven, but the second move depends on revisions.
• If crude re-rallies back above the pre-deal range, cut the thesis quickly and reassess: the trade’s risk/reward depends on a sustained decline in geopolitical tail risk, not just a one-day headline reaction.